We are live on ! Find out more
AVA

Atlas Venture Advisors Portfolio holdings

AUM $122M
1-Year Est. Return 26.28%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
-26.28%
3 Year Est. Return
-22.79%
5 Year Est. Return
-46.44%
10 Year Est. Return
AUM
$198M
AUM Growth
+$8.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 69.18%
2 Healthcare 29.45%
3 Communication Services 1.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBLK
1
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$137M 69.18%
9,823,103
TBIO
2
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$40M 20.18%
3,922,008
LRMR icon
3
Larimar Therapeutics
LRMR
$416M
$9.61M 4.85%
292,184
VRDN icon
4
Viridian Therapeutics
VRDN
$2.13B
$8.77M 4.43%
209,505
SNAP icon
5
Snap
SNAP
$7.32B
$2.7M 1.36%
245,076

Similar funds

Atlas Venture Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Atlas Venture Advisors held 5 positions worth $198M, up 4.5% from $189M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 0%. Atlas Venture Advisors opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 69% of assets, down from 70% a quarter earlier, followed by Healthcare and Communication Services.

  • Atlas Venture Advisors's ten largest holdings make up 100% of its $198M portfolio in Q1 2019.
  • Atlas Venture Advisors opened 0 new positions and closed 0 in Q1 2019.
  • Atlas Venture Advisors's portfolio value rose 4.5% quarter-over-quarter to $198M.

Based on Atlas Venture Advisors's 13F filing for Q1 2019, filed 13 May 2019.